Cooke & Bieler LP Has Increased By $23.39 Million Its Abbott Laboratories (ABT) Holding, Last Week S&W Seed Company (SANW) Coverage

June 20, 2017 - By Peter Erickson

Among 4 analysts covering S&W Seed Company (NASDAQ:SANW), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. S&W Seed Company had 5 analyst reports since August 30, 2015 according to SRatingsIntel. Zacks maintained it with “Buy” rating and $8 target in Sunday, August 30 report. The firm has “Hold” rating given on Friday, October 16 by TheStreet. The rating was maintained by Piper Jaffray with “Overweight” on Thursday, September 17. The company was downgraded on Thursday, May 11 by PiperJaffray. See S&W Seed Company (NASDAQ:SANW) latest ratings:

11/05/2017 Broker: PiperJaffray Old Rating: Overweight New Rating: Neutral Old Target: $6.00 New Target: $4.00 Downgrade
29/03/2017 Broker: B. Riley & Co Rating: Buy New Target: $9.00 Initiates Coverage On

Cooke & Bieler Lp increased Abbott Laboratories (ABT) stake by 25.77% reported in 2016Q4 SEC filing. Cooke & Bieler Lp acquired 615,479 shares as Abbott Laboratories (ABT)’s stock declined 3.42%. The Cooke & Bieler Lp holds 3.00 million shares with $115.38M value, up from 2.39M last quarter. Abbott Laboratories now has $86.03B valuation. The stock rose 0.22% or $0.11 reaching $49 per share. About 400 shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since June 20, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

S&W Seed Company is a global agricultural company. The company has market cap of $68.33 million. The Firm focuses on the breeding, production and sale of alfalfa seed. It currently has negative earnings. In addition to its primary activities in alfalfa seed, it also offers hybrid sorghum and sunflower seed germplasm.

Since January 6, 2017, it had 12 buys, and 14 insider sales for $1.00 million activity. Another trade for 41,293 shares valued at $179,625 was bought by WYNNEFIELD PARTNERS SMALL CAP VALUE LP. $4,525 worth of S&W Seed Company (NASDAQ:SANW) was sold by Jury Dennis Charles on Monday, February 13. $5,854 worth of S&W Seed Company (NASDAQ:SANW) was sold by GREWAL MARK S on Saturday, April 1. On Friday, March 31 the insider BORNT GLEN D sold $61,370. Another trade for 1,100 shares valued at $5,462 was made by Szot Matthew K on Saturday, April 1.

Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.37, from 1.5 in 2016Q3. It turned negative, as 8 investors sold S&W Seed Company shares while 7 reduced holdings. 4 funds opened positions while 13 raised stakes. 11.18 million shares or 3.86% more from 10.76 million shares in 2016Q3 were reported. Kennedy Management reported 818,758 shares. Blackrock Institutional Trust Com Na holds 24,347 shares. Wolverine Asset Lc holds 0% or 25,154 shares in its portfolio. Rmb Management Limited Liability Company accumulated 0.34% or 1.38M shares. Northpointe Ltd Llc reported 0.43% stake. Walleye Trading Limited Company holds 4,300 shares. Thomson Horstmann & Bryant holds 0.15% or 262,810 shares. Bridgeway Management stated it has 0.01% in S&W Seed Company (NASDAQ:SANW). Tower Capital Limited Liability Company (Trc) holds 231 shares. Essex Investment Management Limited has 93,832 shares for 0.07% of their portfolio. Deutsche National Bank & Trust Ag holds 0% of its portfolio in S&W Seed Company (NASDAQ:SANW) for 40,334 shares. Sg Lc invested 0.12% in S&W Seed Company (NASDAQ:SANW). 284,763 were accumulated by Bard Associate. Renaissance Technology Lc has invested 0% in S&W Seed Company (NASDAQ:SANW). Blackrock Investment Management Ltd Limited Liability Company stated it has 0% of its portfolio in S&W Seed Company (NASDAQ:SANW).

It closed at $3.85 lastly. It is down 4.21% since June 20, 2016 and is downtrending. It has underperformed by 20.91% the S&P500.

Among 17 analysts covering Abbott Laboratories (NYSE:ABT), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Abbott Laboratories had 51 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Friday, October 9 with “Outperform”. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) rating on Friday, January 29. RBC Capital Markets has “Outperform” rating and $45 target. Jefferies maintained it with “Buy” rating and $49 target in Thursday, July 14 report. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 23. The firm has “Market Perform” rating given on Friday, January 29 by William Blair. Jefferies maintained the stock with “Buy” rating in Friday, June 16 report. The firm earned “Market Perform” rating on Tuesday, March 14 by BMO Capital Markets. The rating was maintained by Jefferies with “Buy” on Tuesday, March 15. BTIG Research maintained Abbott Laboratories (NYSE:ABT) on Saturday, August 29 with “Buy” rating. The stock of Abbott Laboratories (NYSE:ABT) earned “Overweight” rating by Barclays Capital on Wednesday, October 7.

Since January 31, 2017, it had 1 insider buy, and 20 sales for $8.46 million activity. Watkin Jared had sold 970 shares worth $44,028. The insider NATH DEEPAK S. sold $14,349. $4.20M worth of Abbott Laboratories (NYSE:ABT) was sold by CAPEK JOHN M. 1,601 shares were sold by BIRD ROGER, worth $72,069 on Tuesday, February 28. 12,200 shares were bought by Fussell Stephen R, worth $497,394. $592,157 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Contreras Jaime. The insider ALLEN HUBERT L sold 857 shares worth $38,569.

Cooke & Bieler Lp decreased Carnival (NYSE:CCL) stake by 19,385 shares to 1.37M valued at $71.27M in 2016Q4. It also reduced Chevron (NYSE:CVX) stake by 6,890 shares and now owns 396,404 shares. Umpqua Holdings (NASDAQ:UMPQ) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: